The first Strongbridge Biopharma plc trade was made in Q1 2018.
Since then Jim Simons bought shares nine more times and sold shares on six occasions. The investor completely sold their stake between Q1 2021 and Q4 2021.
Avg closing price
Price range
Sold -1.37 Million shares
Q4 2021
Avg closing price
$2.01
Price range
$1.97
-
$2.06
Sold 4.0% shares (-56.5 Thousand shares)
Q3 2021
Avg closing price
$2.33
Price range
$1.89
-
$3.08
Sold 7.7% shares (-118 Thousand shares)
Q2 2021
Avg closing price
$2.64
Price range
$2.27
-
$3.15
Sold 29.4% shares (-643 Thousand shares)
Q1 2021
Avg closing price
$3.02
Price range
$2.46
-
$3.96
Increased shares by 39.5% (+620 Thousand shares)
Q4 2020
Avg closing price
$2.41
Price range
$1.89
-
$2.84
Increased shares by 25.1% (+315 Thousand shares)
Q3 2020
Avg closing price
$3.37
Price range
$2.10
-
$4.24
Increased shares by 30.1% (+290 Thousand shares)
Q2 2020
Avg closing price
$3.00
Price range
$1.74
-
$4.40
Increased shares by 50.3% (+323 Thousand shares)
Q1 2020
Avg closing price
$2.60
Price range
$1.57
-
$3.51
Increased shares by 210.3% (+435 Thousand shares)
Q4 2019
Avg closing price
$1.92
Price range
$1.47
-
$2.42
Increased shares by 24.4% (+40.5 Thousand shares)
Q3 2019
Avg closing price
$2.69
Price range
$2.29
-
$3.38
Increased shares by 208.0% (+112 Thousand shares)
Q2 2019
Avg closing price
$3.67
Price range
$2.82
-
$4.96
New holding (+54 Thousand shares)
Q1 2019
Avg closing price
$4.92
Price range
$4.42
-
$5.59
Sold -82.8 Thousand shares
Q4 2018
Avg closing price
$4.88
Price range
$3.87
-
$6.40
Sold 52.0% shares (-89.6 Thousand shares)
Q3 2018
Avg closing price
$5.12
Price range
$4.00
-
$6.25
Increased shares by 44.1% (+52.8 Thousand shares)
Q2 2018